Powered by GlobalData

COVID-19 Global Trials Tracker

The Coronavirus Company/Trials Tracker lists clinical trials in all stages of clinical development (from Phase 0 to Phase IV) for COVID-19 indication. This list is updated dynamically based on the GloblaData Pharma Intelligence Center Clinical Trials database.

The Sponsor company is responsible for implementation, data analysis and providing funds for the clinical study.

To view all pipeline pharmaceuticals for COVID-19 indication including preclinical and preregistration, visit the Coronavirus Drugs Tracker.

Trial Title Sponsor Drug Name Trial Phase Trial Status
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study Ansun Biopharma Inc DAS-181 Phase III Ongoing, recruiting
Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI (REVIVAL) Am-Pharma BV Recombinant Human Alkaline Phosphatase Replacement for Acute Renal Failure, Hypophosphatasia, Sepsis and Ulcerative Colitis Phase III Ongoing, recruiting
Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia Qingfeng Pharmaceutical Group Co Ltd xiyanping Phase III Ongoing, recruiting
Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants with Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment Gilead Sciences Inc remdesivir Phase III Completed
Anti-coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (ACT COVID19) Population Health Research Institute; Adult Medicine Research Unit Inc aspirin; rivaroxaban Phase III Ongoing, recruiting
A Real-World Study for Lopinavir/Ritonavir(LPV/r) and Emtricitabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) Regimen in the Treatment of Novel Coronavirus Pneumonia (COVID-19) Sichuan Academy of Medical Sciences &; Sichuan Provincial People’s Hospital; Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital (emtricitabine + tenofovir alafenamide) Phase II Planned
Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children Wuhan Hospital of Traditional Chinese and Western Medicine Gubiao Jiedu Ling Phase II Planned
Safety and Effectiveness of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Acute Respiratory Distress Syndrome of Severe Novel Coronavirus Pneumonia (COVID-19) Nanchang University Affiliated Hospital One umbilical cord mesenchymal stem cells Phase II Ongoing, recruiting
Study for Evaluation of Integrated Traditional Chinese and Western Medicine in the Treatment of Novel Coronavirus Pneumonia (Covid-19) First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; Tianjin Haihe Hospital undisclosed traditional Chinese medicine; western medicine Phase II Ongoing, recruiting
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 Cytodyn Inc leronlimab Phase II Completed
Clinical Study of Camostat Mesylate University of Tokyo camostat mesylate Phase I Planned
Controlled Study of Mavrilimumab in Subjects with Severe Coronavirus 2019 (COVID-19) Pneumonia and Hyperinflammation Kiniksa Pharmaceuticals Ltd mavrilimumab Phase I Planned
A Clinical Trial on AT-H201 of COVID-19 Subjects for Pulmonary Evaluation Who Are on Mechanical Ventilation Atossa Therapeutics Inc ATH-201 Phase I Planned
Study of the Safety of Therapeutic Tx with Immunomodulatory Msc in Adults with Covid-19 Infection Requiring Mechanical Ventilation NantWorks LLC Stem Cell Therapy for Coronavirus Disease 2019 (COVID-19) Phase I Ongoing, recruiting
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Ub-612 Covid-19 Vaccine United Biomedical Inc UB-612 Phase I Ongoing, recruiting
A Single Arm Study of Combination of Traditional Chinese and Western Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19) Hubei Integrated Traditional Chinese and Western Medicine Hospital undisclosed traditional Chinese medicine; western medicine Phase IV Planned
A Randomized, Double-blind, Parallel, Controlled Trial for Comparison of Phosphoric Chloroquine Combined with Standard Therapy and Standard Therapy in Mild/Common Patients with Novel Coronavirus Pneumonia (COVID-19) Jingzhou Central Hospital chloroquine Phase IV Planned
Randomized, Open, Blank Controlled Trial for the Efficacy and Safety of Recombinant Human Interferon Alpha 1beta in the Treatment of Wuhan Patients with Novel Coronavirus Pneumonia (COVID-19) Tongji Hospital recombinant human interferon alpha 1 beta Phase IV Ongoing, recruiting
Novel Coronavirus Pneumonia (COVID-19) Combined with Chinese and Western Medicine Based on ''internal and External Relieving -truncated Torsion'' Strategy Longhua Hospital Shanghai University of TCM undisclosed traditional Chinese medicine; western medicine Phase IV Planned
Clinical Trial of Renin-angiotensin-aldosterone System Inhibitors with Halting Their Administration and the Effect on Clinical Outcomes of Patients with Coronavirus Disease-2019 (Covid-19) Referring to Sina and Imam-khomeini Hospitals in 2020 Tehran University of Medical Sciences undisclosed beta blocker; undisclosed calcium channel blocker Phase IV Completed
Note: for more detailed information please visit the GloblaData Pharma Intelligence Center.
×

To sign up for a free, non-obligatory demo and find out how GlobalData can help your business decode the future – Click here.

If you are a subscriber to the GlobalData Pharma Intelligence Center - Click here to log in